Literature DB >> 22492744

Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N.

Sunil K Pati1, Zdenek Novak, Misty Purser, Nitin Arora, Michael Mach, William J Britt, Suresh B Boppana.   

Abstract

The human cytomegalovirus (HCMV) gM-gN complex is a major target of virus-neutralizing activity, and gN subtypes induce strain-specific antibodies. However, the biological significance of HCMV gN polymorphisms is not known. Neutralizing antibody responses against HCMV gN recombinant viruses were investigated at study entry in 80 healthy HCMV-seropositive women who were monitored for the appearance of new antibody specificities against linear strain-specific epitopes on glycoproteins gH and gB as evidence of HCMV reinfection. Neutralizing activity against all four gN recombinant viruses was seen in 74% of subjects, and 61% of subjects had strain-specific responses. Significantly fewer women (9/39 subjects [23%]) with serological evidence of reinfection had strain-specific neutralizing responses than the women without reinfection (21/41 subjects [51%]). Women with antibodies against at least one of the four linear gB and gH antigens at study entry had higher neutralizing titers against gN-1 (P = 0.006) and gN-2 (P = 0.007). Neutralizing titers of ≥400 against gN-3 (P = 0.043) and gN-4 (P = 0.049) at study entry were associated with longer times to serological evidence of reinfection. The findings demonstrate that HCMV gN elicits strain-specific neutralizing antibody responses and that broader anti-gN neutralizing activity may provide some protection from reinfection with a different virus strain.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492744      PMCID: PMC3370452          DOI: 10.1128/CVI.00092-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  28 in total

1.  Coding potential of laboratory and clinical strains of human cytomegalovirus.

Authors:  Eain Murphy; Dong Yu; Jane Grimwood; Jeremy Schmutz; Mark Dickson; Michael A Jarvis; Gabriele Hahn; Jay A Nelson; Richard M Myers; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

2.  The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.

Authors:  Lucy Rasmussen; Aimee Geissler; Catherine Cowan; Amanda Chase; Mark Winters
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients.

Authors:  Alain Coaquette; Alain Bourgeois; Carine Dirand; Audrey Varin; Wan Chen; Georges Herbein
Journal:  Clin Infect Dis       Date:  2004-06-23       Impact factor: 9.079

4.  Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens.

Authors:  S W Chou
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

5.  Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.

Authors:  W J Britt; L Vugler; E J Butfiloski; E B Stephens
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

6.  Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.

Authors:  S B Boppana; L B Rivera; K B Fowler; M Mach; W J Britt
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

8.  Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.

Authors:  Yasuhiro Abe; Emi Takashita; Kanetsu Sugawara; Yoko Matsuzaki; Yasushi Muraki; Seiji Hongo
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.

Authors:  M Urban; W Britt; M Mach
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus.

Authors:  J E Grundy; S F Lui; M Super; N J Berry; P Sweny; O N Fernando; J Moorhead; P D Griffiths
Journal:  Lancet       Date:  1988-07-16       Impact factor: 79.321

View more
  12 in total

1.  Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity.

Authors:  William J Britt
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

Review 2.  Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades' résumé.

Authors:  Astrid Krmpotić; Jürgen Podlech; Matthias J Reddehase; William J Britt; Stipan Jonjić
Journal:  Med Microbiol Immunol       Date:  2019-03-28       Impact factor: 3.402

Review 3.  Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.

Authors:  Thomas J Gardner; Domenico Tortorella
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

4.  A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.

Authors:  Yaping Liu; Daniel C Freed; Leike Li; Aimin Tang; Fengsheng Li; Edward M Murray; Stuart P Adler; Michael A McVoy; Richard E Rupp; Diane Barrett; Xiaohua Ye; Ningyan Zhang; Karen Beck; Timothy Culp; Rituparna Das; Liping Song; Kalpit Vora; Hua Zhu; Dai Wang; Amy S Espeseth; Zhiqiang An; Luwy Musey; Tong-Ming Fu
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

Review 5.  Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy.

Authors:  William Britt
Journal:  Med Microbiol Immunol       Date:  2015-03-13       Impact factor: 3.402

Review 6.  Subversion of Immune Response by Human Cytomegalovirus.

Authors:  A Raj Kumar Patro
Journal:  Front Immunol       Date:  2019-06-10       Impact factor: 7.561

Review 7.  Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity.

Authors:  Hsuan-Yuan Wang; Sarah M Valencia; Susanne P Pfeifer; Jeffrey D Jensen; Timothy F Kowalik; Sallie R Permar
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.818

8.  Combined genetic variants of human cytomegalovirus envelope glycoproteins as congenital infection markers.

Authors:  Maria-Cristina Arcangeletti; Rosita Vasile Simone; Isabella Rodighiero; Flora De Conto; Maria-Cristina Medici; Davide Martorana; Carlo Chezzi; Adriana Calderaro
Journal:  Virol J       Date:  2015-11-26       Impact factor: 4.099

9.  Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus.

Authors:  Mark R Schleiss; Shane McAllister; Anibal G Armién; Nelmary Hernandez-Alvarado; Claudia Fernández-Alarcón; Jason C Zabeli; Thiruvarangan Ramaraj; John A Crow; Michael A McVoy
Journal:  Viruses       Date:  2014-01-27       Impact factor: 5.048

10.  Molecular characterization of duck enteritis virus CHv strain UL49.5 protein and its colocalization with glycoprotein M.

Authors:  Meng Lin; Renyong Jia; Mingshu Wang; Xinghong Gao; Dekang Zhu; Shun Chen; Mafeng Liu; Zhongqiong Yin; Yin Wang; Xiaoyue Chen; Anchun Cheng
Journal:  J Vet Sci       Date:  2014-04-02       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.